531TiP - CANOPY-A: A phase III, placebo-controlled study of canakinumab as adjuvant therapy in patients (pts) with surgically resected NSCLC

B.c Cho , Gee Chen Chang + Show 18 more

Open Access

https://doi.org/10.1093/annonc/mdz437.056

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Nov 1, 2019
License type: publisher-specific-oa

Affiliation: Yonsei University, Taichung Veterans General Hospital, Chiang Mai University, Aix-Marseille University, University Hospital Heidelberg, Tris Pharma (United States), Sarah Cannon, Hospital de Câncer de Barretos, Policlinico S.Orsola-Malpighi, The US Oncology Network, Chang Gung Memorial Hospital, Research Institute Hospital 12 de Octubre, Songklanagarind Hospital, Novartis (United States), Shanghai Chest Hospital, Chonnam National University Hwasun Hospital, National Taiwan University Hospital

#Boehringer Ingelheim #Research Grant + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

531TiP - CANOPY-A: A phase III, placebo-controlled study of canakinumab as adjuvant therapy in patients (pts) with surgically resected NSCLC

Full Text

Published version (

Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title

Journal

Date

Author

View more papers

Translate this paper in your preferred language
Listen to the abstract of this paper

Save
Share
Export